Cancer Therapies (Clinical Trials)

Large-Scale Production of Biotherapeutic Begins

Published in AIDS Weekly, November 29th, 1999

Immtech International, Inc., announced that it is entering into the large-scale manufacturing phase of its biotherapeutic recombinant mCRP protein (rmCRP) for human clinical trials in cancer.

Immtech conducted human trials with HIV patients in 1996, and it plans to expand upon human trials of its unique immune-stimulating protein in 2000 with cancer and HIV patients.

"A key issue in the large-scale production of rmCRP has been resolved, allowing Immtech to quickly and efficiently purify large amounts of the protein suitable for human clinical trials," said Dr. Lawrence A. Potempa, Immtech. "Integral to the development of any therapeutic agent is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1999-11-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry